Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Hydroxyurea
United Therapeutics Europe Ltd
Thrombocythemia
1 trial -
Hypofractionated Radiation Therapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Hypofractionated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Ibuprofen
United Therapeutics Europe Ltd
Immune System and Related Disorders
1 trial -
Immune-enhancing nutritional beverage
United Therapeutics Europe Ltd
Mitigation of Immune Function Decrements in Response to Stress
1 trial -
Immunosuppressive therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
In-stent Restenosis Lesion
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
The First People's Hospital of Lianyungang
CD30+ Peripheral T-cell Lymphoma
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
Hospital Authority, Hong Kong
CD30+ Peripheral T-cell Lymphoma
1 trial -
Induction therapy-Pro regimen
The First People's Hospital of Lianyungang
Diffuse Large B-Cell Lymphoma
1 trial -
Infant and young child feeding
United Therapeutics Europe Ltd
Growth; Stunting, Nutritional
1 trial -
Infasurf
Summit Therapeutics
Respiratory Distress Syndrome
1 trial -
Insulin
United Therapeutics Europe Ltd
Burns
1 trial -
Insulin Aspart Injection๏ผUBLINยฎ๏ผ
United Therapeutics Europe Ltd
Pharmacokinetics and Pharmacodynamics
1 trial -
Intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Intraoperative Radiation Therapy in Malignant Cerebral Tumor
The First People's Hospital of Lianyungang
Glioblastoma
1 trial -
Intraoperative identification method
Xijing Hospital
Thyroid Cancer
1 trial -
Intrauterine lavage therapy
The First People's Hospital of Lianyungang
Intrauterine Adhesions
1 trial -
Intravenous Vitamin C
United Therapeutics Europe Ltd
Burns
1 trial -
Intravenous administration of ferric carboxymaltose
United Therapeutics Europe Ltd
Lung Hypoxia
1 trial -
Intravenous sedation
United Therapeutics Europe Ltd
Lower Back Pain
1 trial -
Ipilimumab
Iovance Biotherapeutics B.V.
Metastatic Melanoma
1 trial -
Jelly confectionary Snakes
United Therapeutics Europe Ltd
POSTOP NAUSEA VOMITING
1 trial -
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources